BDR Pharmaceuticals – Pharmaceutical Company
BDR
BDR Pharmaceuticals International Pvt. Ltd. is a privately held Indian pharmaceutical company founded in 2002 by Dharmesh Shah, who previously worked at Hetero Drugs. Its registered office is in Mumbai.
BDR started by making active ingredients for critical care medicines and later moved into finished dosage forms. Its main areas today are oncology, critical care, neurology and gynaecology. Manufacturing is located in Gujarat, near Vadodara.
BDR is known for bringing generics of expensive medicines to the Indian market. According to its founder, it was the first Indian company to launch generic abiraterone and the first generics maker to bring the antifungal caspofungin to India. In 2013 BDR applied for a compulsory licence for dasatinib (the original is Bristol-Myers Squibb's Sprycel), but the Indian patent office rejected the application.
Outside India, BDR works through partners, including in Brazil and the CIS.
Unifarm carries BDR's prostate cancer medicine: Bdenza (enzalutamide).